Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Therma Bright Inc (TSV: THRM )

0.0350 -0.0050 (-12.50%)
Streaming Delayed Price Updated: 3:41 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,657
Open 0.0350
Bid (Size) 0.0350 (16,380)
Ask (Size) 0.0400 (800)
Prev. Close 0.0400
Today's Range 0.0350 - 0.0400
52wk Range 0.0050 - 0.1000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Therma Bright Welcomes Healthcare and Technology Expert Steve Raysely to its Advisory Board
Toronto, Ontario--(Newsfile Corp. - February 4, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a... 
Via Newsfile
Therma Bright Reaffirms Its Position As A Key Player In The $4.2 Billion Compression Market With New Venowave Orders
Via AB Newswire

Performance

YTD
N/A
N/A
1 Month
-12.50%
-12.50%
3 Month
+40.00%
+40.00%
6 Month
-53.33%
-53.33%
1 Year
+75.00%
+75.00%

More News

Read More
Therma Bright Reaffirms Its Position As A Key Player In The $4.2 Billion Compression Market With New Venowave Orders
Via News Direct
Therma Bright Inc. (OTC: TBRIF) Expands in $6.72 Billion Compression Market
Via AB Newswire
Therma Bright Inc. (OTC: TBRIF) Expands in $6.72 Billion Compression Market
Via News Direct
Therma Bright Secures Purchase Order For 1,750 Venowave W5 Units From National Distributor - DME Authority of Nashville, TN
Via Newsfile
Therma Bright Secures Purchase Order For Initial 100 Venowave Units From New National Distribution Partner - Valor Medical of San Antonio
Via Newsfile
Therma Bright Signs LOI For U.S. Distribution Network Expansion For Venowave With DME Authority
Via Newsfile
Therma Bright Congratulates Investment Partner Inretio's Promising Initial Results from PREVA(TM) Device's First Clinical Phase
Via Newsfile
Therma Bright's Distribution Partners Achieve 100% HCPCS Code Reimbursement In Under 60 Days
Via Newsfile
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
Via Newsfile
Therma Bright's Investment Partnership InStatin Joins Forces with InVixa to Enhance Its Patent Portfolio For The Development Of Innovative Respiratory Solutions
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
Via Newsfile
Therma Bright Welcomes Medical Device & Pharmaceutical Veteran Douglas S. Sommerville to Its Advisory Board
Via Newsfile
Topics Intellectual Property Retirement
Exposures Intellectual Property Pension
Therma Bright Congratulates John Patton, PhD of InStatin on Receiving the Prestigious Charles G. Thiel Award
Via Newsfile
Therma Bright Major Milestone: Portfolio Company Inretio's Preva(R) Device Achieves 3rd Human Trial Success
Via Newsfile
RETRANSMISSION: Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Via Newsfile
Therma Bright Secures Nationwide U.S. Distribution Partner For Venowave
Via Newsfile
Therma Bright's Venowave VW5 Secures Permanent HCPCS Code E0683 from U.S. DHHS's Centers for Medicare & Medicaid Services
Via Newsfile
Therma Bright's AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Therma Bright Welcomes Medical & Pharmaceutical Veteran Michael Raimondo to Its Advisory Board
Via Newsfile
Therma Bright Expands InStatin Investment
Via Newsfile
Therma Bright Receives Positive Notification from U.S. DHHS's Centers for Medicare & Medicaid (CMS)
Via Newsfile
Therma Bright's Venowave VW5 Secures FDA 510K Approval
Via Newsfile
Exposures Product Safety
Therma Bright Engages Independent Trading Group as Market Maker
Via Newsfile
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.